St. Jude, AHA target heart failure outcomes; FDA approves faster Roche HBV, HCV tests;

@FierceMedDev: Check out this year's Fierce 15: The new strategic med tech mania sets the stage for 2015's Fierce 15. Feature | Follow @FierceMedDev

@VarunSaxena2: #TCT15: Startup's minimally invasive mitral valve repair tech shows promise in feasibility study. Story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: European investor shells out $118M for DNA testing outfit to boost animal Dx offerings. Article | Follow @EmilyWFierce

> The New York Times has published an expose on an Indiana surgeon who has been doing unnecessary implants of cardiac devices. Story

> St. Jude Medical ($STJ) has committed $1 million to the American Heart Association for research to improve outcomes for heart failure patients. More

> The FDA has approved the cobas HBV and cobas HCV viral load tests from Roche ($RHHBY), which the company said is the fastest assay available that provide up to 96 results in less than 3.5 hours. More

Biotech News

@FierceBiotech: ICYMI Friday: Biotech notches another $2B VC quarter, but can it last? Story | Follow @FierceBiotech

@JohnCFierce: Shire hit with another setback as FDA rejects top pipeline drug- Does anyone think that Ornskov is a good CEO? Article | Follow @JohnCFierce

@DamianFierce: Not often a company issues two separate statements on a single drug rejection. More | Follow @DamianFierce

> Genocea halts its antibiotic vaccine program after a Phase II failure. Story

> Basilea plots $190M IPO on Nasdaq as it circles a PhIII antibiotic study. Article

Pharma News

@FiercePharma: ICYMI: Boehringer looks for Pradaxa boost from now FDA-approved antidote. Article | Follow @FiercePharma

@EricPFierce: Pests, lack of data integrity thwart another Indian API maker, this time Unimark Remedies. More | Follow @EricPFierce

@CarlyHFierce: Shire's eye drug setback gives Allergan's Restasis a temporary reprieve. Story | Follow @CarlyHFierce

> J&J chalks up a win in first Tylenol liver-damage case to go to trial. Story

> Regeneron doubles investment, adding 200 more jobs to plant in Ireland. Article

Animal Health News

> European investor shells out $118M for DNA testing outfit to boost animal Dx offerings. Story

> Dog study validates Blaze 'tumor paint' for guiding surgery. Report

> Nexvet launches field trial of treatment for feline osteoarthritis. More

> Ceva, Harrisvaccines nab USDA contracts for bird flu vaccines. Article

> Dogs with cleft palates add to knowledge of condition in children. Story

Biotech IT News

> Venter's Human Longevity starts $50,000 health testing service. News

> LabKey lands data-management deal with 100,000 Genomes Project. More

> EU consortium creates large toxin database for drug discovery. Report

> Scripps teams up to apply genomics to stem cell quality control. Story

> 23andMe raises $115M as investors buy into data-driven drug discovery vision. Article

Pharma Marketing News

> One year after FDA nod, Eli Lilly's Trulicity launches first consumer campaign. Item

> Merck KGaA exits 'sea of sameness' with futuristic rebrand. Editor's corner

> Pacira sues for free speech; FDA pulls off-label warning letter. What gives? More

> Bayer consumer biz on digital agency hunt, in shift from 'TV-centric' to 'channel-agnostic.' Article

> Influential cancer group releases first batch of affordability info on cancer meds. Item

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.